{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:45:29Z","timestamp":1792896329368,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009666","name":"Salt Science Research Foundation","doi-asserted-by":"publisher","award":["1642"],"award-info":[{"award-number":["1642"]}],"id":[{"id":"10.13039\/100009666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K09583"],"award-info":[{"award-number":["17K09583"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jjcc.2021.03.004","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T04:20:55Z","timestamp":1617337255000},"page":"261-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG"],"prefix":"10.1016","volume":"78","author":[{"given":"Taishi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2021.03.004_bib0001","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0002","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCRESAHA.110.230698","article-title":"cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes","volume":"108","author":"Stangherlin","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0003","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00192547","article-title":"Evaluation of the effect of phosphodiesterase inhibitors on mortality in chronic heart failure patients. A meta-analysis","volume":"46","author":"Nony","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0004","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI24178","article-title":"Protein kinase cascades in the regulation of cardiac hypertrophy","volume":"115","author":"Dorn","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cardiores.2004.04.002","article-title":"Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes","volume":"63","author":"Fiedler","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0006","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1073\/pnas.162100799","article-title":"Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes","volume":"99","author":"Fiedler","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0007","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1172\/JCI27702","article-title":"TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling","volume":"116","author":"Kuwahara","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0008","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.yjmcc.2009.11.015","article-title":"Cyclic GMP\/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation. Novel mechanism of cardiac stress modulation by PDE5 inhibition","volume":"48","author":"Koitabashi","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0009","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00395-010-0098-z","article-title":"Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2","volume":"105","author":"Klaiber","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0010","first-page":"408","article-title":"Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice","volume":"119","author":"Takimoto","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0011","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/CIRCULATIONAHA.107.732990","article-title":"Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart","volume":"117","author":"Tokudome","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0012","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41586-019-0895-y","article-title":"PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress","volume":"566","author":"Ranek","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.593585","article-title":"Phosphorylation modifications regulating cardiac protein quality control mechanisms","volume":"11","author":"Mishra","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0014","doi-asserted-by":"crossref","first-page":"H33","DOI":"10.1152\/ajpheart.2000.278.1.H33","article-title":"Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs","volume":"278","author":"Lainchbury","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Pt 2","key":"10.1016\/j.jjcc.2021.03.004_bib0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1113\/jphysiol.2001.014126","article-title":"Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes","volume":"540","author":"Layland","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCRESAHA.108.184408","article-title":"Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs","volume":"104","author":"Kr\u00fcger","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0017","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1161\/CIRCULATIONAHA.111.048520","article-title":"Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo","volume":"124","author":"Bishu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/hh0102.103222","article-title":"cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium","volume":"90","author":"Wegener","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/bbrc.1996.1472","article-title":"Localization of nitric oxide synthase in human skeletal muscle","volume":"227","author":"Frandsen","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.RES.0000178451.08719.5b","article-title":"Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria","volume":"97","author":"Costa","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0021","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1423-0127-16-70","article-title":"Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release","volume":"16","author":"Borutaite","year":"2009","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0022","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0008-6363(02)00439-X","article-title":"Mitochondrial K(ATP) channels: role in cardioprotection","volume":"55","author":"Oldenburg","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0023","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.2337\/db09-0393","article-title":"Natriuretic peptides\/cGMP\/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity","volume":"58","author":"Miyashita","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0024","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1172\/JCI64526","article-title":"Natriuretic peptides enhance the oxidative capacity of human skeletal muscle","volume":"122","author":"Engeli","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0025","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jmb.2007.11.053","article-title":"cGMP-binding prepares PKG for substrate binding by disclosing the C-terminal domain","volume":"375","author":"Alverdi","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0026","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.str.2016.03.009","article-title":"Crystal structure of PKG I:cGMP complex reveals a cGMP-mediated dimeric interface that facilitates cGMP-induced activation","volume":"24","author":"Kim","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0027","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.str.2013.09.021","article-title":"Structural basis for cyclic-nucleotide selectivity and cGMP-selective activation of PKG I","volume":"22","author":"Huang","year":"2014","journal-title":"Structure"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0028","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/35004606","article-title":"Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta","volume":"404","author":"Schlossmann","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0029","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1074\/jbc.M117.781260","article-title":"NMR insight into myosin-binding subunit coiled-coil structure reveals binding interface with protein kinase G-I\u03b1 leucine zipper in vascular function","volume":"292","author":"Sharma","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0030","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1074\/jbc.275.7.4897","article-title":"Binding and phosphorylation of a novel male germ cell-specific cGMP-dependent protein kinase-anchoring protein by cGMP-dependent protein kinase Ialpha","volume":"275","author":"Yuasa","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0031","doi-asserted-by":"crossref","first-page":"25393","DOI":"10.1074\/jbc.M114.575894","article-title":"Crystal structure of the cGMP-dependent protein kinase II leucine zipper and Rab11b protein complex reveals molecular details of G-kinase-specific interactions","volume":"289","author":"Reger","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0032","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1126\/science.1144318","article-title":"Cysteine redox sensor in PKGIa enables oxidant-induced activation","volume":"317","author":"Burgoyne","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0033","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1074\/jbc.C117.787358","article-title":"The activity of cGMP-dependent protein kinase I\u03b1 is not directly regulated by oxidation-induced disulfide formation at cysteine 43","volume":"292","author":"Kalyanaraman","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0034","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/db17-0965","article-title":"Protein kinase G activation reverses oxidative stress and restores osteoblast function and bone formation in male mice with type 1 diabetes","volume":"67","author":"Kalyanaraman","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0035","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jmb.2007.08.049","article-title":"Interactions between the leucine-zipper motif of cGMP-dependent protein kinase and the C-terminal region of the targeting subunit of myosin light chain phosphatase","volume":"373","author":"Lee","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0036","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nm.2603","article-title":"Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension","volume":"18","author":"Prysyazhna","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0037","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/d41586-019-00508-z","article-title":"Fresh evidence overturns the identification of a factor involved in blood-vessel dilation","volume":"566","author":"Kass","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0038","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41586-019-0947-3","article-title":"Singlet molecular oxygen regulates vascular tone and blood pressure in inflammation","volume":"566","author":"Stanley","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0039","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/HYPERTENSIONAHA.114.04281","article-title":"Protein kinase G I\u03b1 oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide","volume":"64","author":"Stubbert","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCULATIONAHA.118.037398","article-title":"Blood pressure-lowering by the antioxidant resveratrol is counterintuitively mediated by oxidation of cGMP-dependent protein kinase","volume":"140","author":"Prysyazhna","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0041","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/CIRCULATIONAHA.112.101287","article-title":"Nitroglycerin fails to lower blood pressure in redox-dead Cys42Ser PKG1\u03b1 knock-in mouse","volume":"126","author":"Rudyk","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0042","doi-asserted-by":"crossref","first-page":"16791","DOI":"10.1074\/jbc.RA118.004363","article-title":"Oxidation of cysteine 117 stimulates constitutive activation of the type I\u03b1 cGMP-dependent protein kinase","volume":"293","author":"Sheehe","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0043","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1172\/JCI80275","article-title":"Prevention of PKG1\u03b1 oxidation augments cardioprotection in the stressed heart","volume":"125","author":"Nakamura","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0044","doi-asserted-by":"crossref","first-page":"17427","DOI":"10.1074\/jbc.M116.724070","article-title":"Phosphodiesterase 5 inhibition limits doxorubicin-induced heart failure by attenuating protein kinase G I\u03b1 oxidation","volume":"291","author":"Prysyazhna","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0045","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCRESAHA.119.315714","article-title":"PKG1\u03b1 cysteine-42 redox state controls mTORC1 activation in pathological cardiac hypertrophy","volume":"127","author":"Oeing","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0046","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004740","article-title":"Prevention of PKG-1\u03b1 oxidation suppresses antihypertrophic\/antifibrotic effects From PDE5 inhibition but not sGC stimulation","volume":"11","author":"Nakamura","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0047","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/CIRCULATIONAHA.109.906818","article-title":"Oxidative stress regulates left ventricular PDE5 expression in the failing heart","volume":"121","author":"Lu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0048","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/CIRCULATIONAHA.112.090977","article-title":"Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling","volume":"126","author":"Zhang","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0049","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCRESAHA.111.259242","article-title":"Pressure-overload-induced subcellular relocalization\/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation","volume":"110","author":"Tsai","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0050","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1096\/fj.00-0538com","article-title":"Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure","volume":"15","author":"Senzaki","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0051","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/CIRCRESAHA.110.226712","article-title":"Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes","volume":"107","author":"Castro","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0052","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCRESAHA.109.207381","article-title":"S-nitrosylation in cardiovascular signaling","volume":"106","author":"Lima","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0053","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1089\/ars.2012.4824","article-title":"Nitric oxide synthases in heart failure","volume":"18","author":"Carnicer","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0054","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI21968","article-title":"Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load","volume":"115","author":"Takimoto","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ncb775","article-title":"Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide","volume":"4","author":"Zabel","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0056","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1172\/JCI59701","article-title":"Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes","volume":"122","author":"Bordicchia","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0057","doi-asserted-by":"crossref","first-page":"eaam6870","DOI":"10.1126\/scisignal.aam6870","article-title":"Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance","volume":"10","author":"Wu","year":"2017","journal-title":"Sci Signal"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0058","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.beem.2016.09.002","article-title":"The role of BAT in cardiometabolic disorders and aging","volume":"30","author":"Blondin","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0059","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1161\/CIRCULATIONAHA.106.643536","article-title":"Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5","volume":"115","author":"Takimoto","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0060","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1161\/CIRCULATIONAHA.111.048520","article-title":"Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo","volume":"124","author":"Bishu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0061","doi-asserted-by":"crossref","first-page":"26286","DOI":"10.1016\/S0021-9258(19)74313-0","article-title":"Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation","volume":"268","author":"M\u00e9ry","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0062","doi-asserted-by":"crossref","first-page":"E731","DOI":"10.1210\/jc.2011-2839","article-title":"Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?","volume":"97","author":"Pivovarova","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0063","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2018.06.002","article-title":"Natriuretic peptide based therapeutics for heart failure: cenderitide: a novel first-in-class designer natriuretic peptide","volume":"281","author":"Ichiki","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0064","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0065","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/CIRCULATIONAHA.117.030490","article-title":"Acute enhancement of cardiac function by phosphodiesterase type 1 inhibition","volume":"138","author":"Hashimoto","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0066","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI111742","article-title":"Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside","volume":"75","author":"Jaski","year":"1985","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jjcc.2021.03.004_bib0067","article-title":"Phosphodiesterase III inhibitors for heart failure","author":"Amsallem","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0068","doi-asserted-by":"crossref","first-page":"13650","DOI":"10.1073\/pnas.0804738105","article-title":"Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions","volume":"105","author":"Wilson","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0069","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0070","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature14332","article-title":"Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0071","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121739","article-title":"Marked disparity of microRNA modulation by cGMP-selective PDE5 versus PDE9 inhibitors in heart disease","volume":"3","author":"Kokkonen-Simon","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0072","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjp.0707409","article-title":"Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling","volume":"152","author":"Burley","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0073","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCRESAHA.114.302614","article-title":"Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation","volume":"114","author":"Seo","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0074","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jacc.2011.09.086","article-title":"Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection","volume":"59","author":"Kukreja","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jjcc.2013.03.018","article-title":"Beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy","volume":"62","author":"Jin","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0076","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/eurjhf\/hfr147","article-title":"Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study","volume":"14","author":"Guazzi","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0077","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/eurheartj\/ehv336","article-title":"Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial","volume":"36","author":"Hoendermis","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0078","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.yjmcc.2008.12.008","article-title":"Pressure-overload magnitude-dependence of the anti-hypertrophic efficacy of PDE5A inhibition","volume":"46","author":"Nagayama","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0079","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.14-0106","article-title":"Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study","volume":"146","author":"Bonderman","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0080","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0081","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12933-015-0309-x","article-title":"The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus","volume":"14","author":"M\u00e1ty\u00e1s","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0082","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0083","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0084","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2021.03.004_bib0085","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jacc.2019.05.067","article-title":"Hemodynamic, hormonal, and renal actions of phosphodiesterase-9 inhibition in experimental heart failure","volume":"74","author":"Scott","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508721000599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508721000599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:05:27Z","timestamp":1760274327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508721000599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0914508721000599"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2021.03.004","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2021.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of Japanese College of Cardiology.","name":"copyright","label":"Copyright"}]}}